- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Gerenova J, Manolova I, Stanilova S
Serum Levels of Interleukin - 23 and Interleukin - 17 in Hashimoto’s Thyroiditis
Acta Endo (Buc) 2019, 15 (1): 74-79doi: 10.4183/aeb.2019.74
Context. Overproduction of proinflammatory
cytokines plays a significant role in the pathogenesis of
Hashimoto’s thyroiditis (HT). Recent studies revealed a
prominent role of newly discovered Th17 subset in the
induction of autoimmune disorders and that the signaling
induced by IL-23 on Th17 cells is crucial to obtain a
pathogenic and sustained phenotype. The objective of this
study was to provide the involvement of interleukin IL-23/
IL-17 axis in pathologic processes.
Design. Serum levels of IL-23 and IL-17 in controls
and HT patients were studied in different stages of disease
activity.
Subjects and methods. We investigated 93 patients
with HT: 33 patients with newly diagnosed euthyroid HT
(Group I), 11 patients with newly diagnosed hypothyroid
HT (Group II), and 49 subjects treated with Levothyroxine
(Group III). Thirty healthy subjects were included as
controls. Concentrations of IL-23 and IL-17 in the serum
samples of patients and controls were evaluated by enzymelinked
immunosorbent assay.
Results. Serum level of IL-23 was significantly
higher in all HT patients (p<0.0001) as well as in subgroups
of patients in comparison with controls (p<0.01). Serum
concentrations of IL-17 were statistically increased in the
group of HT patients (p=0.014); the differences in IL-17
levels between groups I and III in comparison to healthy
controls were also significant, but not for group II.
Conclusions. Our results highlight the involvement
of the IL-23/IL-17 axis in the development of HT and its
severity. Moreover, upregulated secretion of IL-23 could be
a biomarker for progression and monitoring of HT.
Keywords: Hashimoto’s thyroiditis, Interleukin-23,
Interleukin-17, ultrasonography, fibrosis.
Correspondence: Julieta Gerenova MD, Trakia University, Medical Faculty, Endocrinology, 11, Armeiska street, Stara Zagora, 6000,
Bulgaria, E-mail: jgerenova@mf.uni-sz.bg